Skip to Content

iBio Inc IBIO

Morningstar Rating
$1.90 +0.12 (6.74%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IBIO is trading within a range we consider fairly valued.
Price
$1.78
Fair Value
$3.34
Uncertainty
Extreme
1-Star Price
$142.16
5-Star Price
$8.19
Economic Moat
Xdzr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IBIO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.78
Day Range
$1.751.93
52-Week Range
$1.0226.20
Bid/Ask
$1.95 / $1.98
Market Cap
$16.36 Mil
Volume/Avg
18 / 4.3 Mil

Key Statistics

Price/Earnings (Normalized)
0.03
Price/Sales
39.28
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
23

Valuation

Metric
IBIO
Price/Earnings (Normalized)
0.03
Price/Book Value
0.61
Price/Sales
39.28
Price/Cash Flow
Price/Earnings
IBIO

Financial Strength

Metric
IBIO
Quick Ratio
0.13
Current Ratio
0.91
Interest Coverage
−185.99
Quick Ratio
IBIO

Profitability

Metric
IBIO
Return on Assets (Normalized)
−35.83%
Return on Equity (Normalized)
−101.23%
Return on Invested Capital (Normalized)
−46.27%
Return on Assets
IBIO
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRQsjflfmjbWkwq$557.8 Bil
VRTX
Vertex Pharmaceuticals IncHlnwfygfcTdpghbd$104.7 Bil
REGN
Regeneron Pharmaceuticals IncVnclmqgDgcwyzx$99.6 Bil
MRNA
Moderna IncHtkvftdZhbp$38.8 Bil
ARGX
argenx SE ADRXfspbbsKbqkg$21.4 Bil
BNTX
BioNTech SE ADRHdnngsxPbwdx$21.3 Bil
ALNY
Alnylam Pharmaceuticals IncSwqysfrsGnnvrx$18.4 Bil
BMRN
Biomarin Pharmaceutical IncNvxfckftjLxcsfj$17.5 Bil
RPRX
Royalty Pharma PLC Class AXyhzgqdgcFlmrflp$12.4 Bil
INCY
Incyte CorpXxtxyckCzwbk$11.9 Bil

Sponsor Center